Systematic Treatment of Central Retinal Vein
                    Occlusion

M.-L. Dari; C. Nguyen; T. J. Wolfensberger; J.-A. C. Pournaras

doi:10.1055/s-0032-1328368

Klinische Monatsblätter für Augenheilkunde, Inhaltsverzeichnis

Klin Monbl Augenheilkd 2013; 230(4): 434-436
DOI: 10.1055/s-0032-1328368

Der interessante Fall

Georg Thieme Verlag KG Stuttgart · New York

Systematic Treatment of Central Retinal Vein Occlusion

Systematische Therapie der zentralen retinalen Venenokklusion

M.-L. Dari

¹Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland (Chairman: Professor Zografos Leonidas)

,

C. Nguyen

¹Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland (Chairman: Professor Zografos Leonidas)

,

T. J. Wolfensberger

¹Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland (Chairman: Professor Zografos Leonidas)

,

J.-A. C. Pournaras

¹Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland (Chairman: Professor Zografos Leonidas)

References
1 Hayreh SS, Fraterrigo L, Jonas J. Central retinal vein occlusion associated with cilioretinal artery occlusion. Retina 2008; 28: 581-594
2 Glueck CJ, Hutchins RK, Jurantee J et al. Thrombophilia and retinal vascular occlusion. Clin Ophthalmol 2012; 6: 1377-1384
3 Mruthyunjaya P, Wirostko WJ, Chandrashekhar R et al. Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina 2006; 26: 285-291
4 Donati G, Mavrakanas N, Pournaras CJ. [Isovolemic hemodilution in the management of the acute phase of central retinal vein occlusion: a pilot study]. J Fr Ophtalmol 2009; 32: 750-756
5 Karia N. Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol 2010; 4: 809-816
6 Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology 2011; 118: 119-133.e1-2
7 Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central vein occlusion. Ophthalmic Surg Lasers Imaging 2005; 36: 336-339
8 Varma R, Bressler NM, Suñer I et al. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology 2012; 119: 2108-2118
9 Gregori NZ, Gaitan J, Rosenfeld PJ et al. Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. Retina 2008; 28: 1325-1337
10 Kim NR, Chin HS. Progression of impending central retinal vein occlusion to the ischemic variant following intravitreal bevacizumab. Korean J Ophthalmol 2010; 24: 179-181